share_log

Addex Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Growth Equity Opportunities Fund IV, LLC(6.4%),New Enterprise Associates 15, L.P.(6.4%), etc.

Addex Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Growth Equity Opportunities Fund IV, LLC(6.4%),New Enterprise Associates 15, L.P.(6.4%)等

美股SEC公告 ·  2023/12/08 14:11
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息